Accueil
Détail de l'auteur
Auteur L. MONTANARI |
Documents disponibles écrits par cet auteur (25)
Ajouter le résultat dans votre panier Faire une suggestion Affiner la recherche
Rapport
OEDT = EMCDDA ; J. FOUNTAIN ; G. BURKHART ; L. MONTANARI | Lisbon : OEDT / EMCDDA | Technical reports | 2017This report provides an overview of the various types of brief interventions (BIs) currently used in European countries in the field of substance use, particularly illicit drugs. Targeted at policymakers and practitioners alike, it covers more t[...]Article : Périodique
G. QUAGLIO ; A. PIRONA ; G. ESPOSITO ; T. KARAPIPERIS ; H. BRAND ; G. DOM ; L. BERTINATO ; L. MONTANARI ; F. KIEFER ; G. CARRA |Background: Little is known about the knowledge and use of technology-based interventions (TBIs) by health personnel working in the addiction field across Europe. Methods: An online questionnaire was designed using SurveyMonkey® in order to det[...]Article : Périodique
A. PIRONA ; A. BO ; D. HEDRICH ; M. FERRI ; N. VAN GELDER ; I. GIRAUDON ; L. MONTANARI ; R. SIMON ; J. MOUNTENEY |Background: The availability of new psychoactive substances (NPS) in Europe has rapidly increased over the last decade. Although prevalence levels of NPS use remain low in the general European population, there are serious concerns associated wi[...]NouveautéRapport
OEDT = EMCDDA ; L. VANDAM ; P. BORLE ; L. MONTANARI ; T. SURMONT ; A. PIRONA ; D. HEDRICH ; A. GALLEGOS ; N. SINGLETON ; J. MOUNTENEY ; P. GRIFFITHS | Lisbon : OEDT / EMCDDA | Rapid communication | 2018This report looks at the use of new psychoactive substances (NPS) in prison settings. This is a rapidly developing phenomenon, but empirical data are currently scarce and patchy. There is growing evidence that NPS are responsible for a large sha[...]Article : Périodique
L. MONTANARI ; L. ROYUELA ; S. MAZZILLI ; L. VANDAM ; E. ALVAREZ ; N. LLORENS ; L. CARAPINHA ; K. GROHMANNOVA ; L. ISAJEVA ; L. IGNATAVICIUTE ; I. KVATERNIK ; J. SIEROSLAWSKI ; A. MALCZEWSKI ; E. PLETTINCKX ; R. SENDINO ; A. TORRES ; I. YASEMI ; L. TAVOSCHI ; V. MRAVCIK |Substance use is a global phenomenon that is particularly affecting the prison population. This study aimed to describe the prevalence of drug use among people in prison before and during incarceration in seven European countries and to compare [...]Article : Périodique
Current data on the prevalence of prior illicit drug use among the prison population in Europe is scarce. The aim of this study is to identify the prevalence of illicit drug use prior to incarceration, as reported by studies conducted in 30 Euro[...]Rapport
OEDT = EMCDDA ; L. MONTANARI ; L. ROYUELA ; I. HASSELBERG ; L. VANDAM | Lisbon : OEDT / EMCDDA | Insights, ISSN 1606-1683 | 2021FRANÇAIS : Ce rapport examine en profondeur un large éventail de problèmes en milieu carcéral, notamment la consommation de drogues et ses méfaits, les réponses sanitaires et sociales et l'approvisionnement en drogues. Il note que, si, dans pl[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; D. THANKI ; E. KALAMARA ; A. NOOR ; L. MONTANARI ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Some drug users go on to develop more severe forms of use, defined by the EMCDDA as 'high-risk drug use': 'recurrent drug use that is causing actual harms (negative consequences) to the person (including dependence, but also other health, psycho[...]Rapport
OEDT = EMCDDA ; T. GROSHKOVA ; D. HEDRICH ; M. FERRI ; L. MONTANARI | Lisbon : OEDT / EMCDDA | EMCDDA Papers, ISSN 2315-1463 | 2014Today, in most European countries, residential treatment programmes form an important element of the range of treatment and rehabilitation options for drug users. The aim of this paper is to provide a Europe-wide overview of the history and avai[...]Article : Périodique
L. MONTANARI ; M. PASINETTI ; B. GUARITA ; L. ROYUELA ; K. MULLIGAN ; J. VICENTE ; D. KLEMPOVA ; A. PIRONA ; A. GYARMATHY |The aim of this article is to explore the prevalence of primary illicit stimulant use among people who enter drug treatment in Europe. Drawing on information provided by European Union treatment centres in 2009 (excluding Latvia, Lithuania, Port[...]Article : Périodique
L. MONTANARI ; A. PIRONA ; B. GUARITA ; D. HEDRICH ; J. MOUNTENEY ; J. VICENTE |ENGLISH: OBJECTIVE: The article describes an epidemiological indicator called Treatment Demand Indicator (TDI). The TDI aims to provide professionals and researchers with a common European methodology for collecting and reporting core data on d[...]Chapitre
C. CARPENTIER ; L. ROYUELA ; L. MONTANARI ; P. DAVIS ; S. KINNER ; J. D. RICH | New York : Oxford University Press | 2018This chapter provides an overview of drug use in prison. It is centered on illicit drug use in Europe, where the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) has been collecting aggregated data from various sources for 15 yea[...]Article : Périodique
L. MONTANARI ; R. TELTZROW ; S. VANMALDEREN ; R. RANIERI ; J. A. MARTIN PELAEZ ; L. VANDAM ; J. MOUNTENEY ; A. PIRONA ; F. MEROUEH ; I. GIRAUDON ; J. MATIAS ; K. SKARUPOVA ; L. ROYUELA ; J. MOREL D'ARLEUX |Purpose: This paper aims to describe the impact of the COVID-19 containment measures on the provision of drug treatment and harm reduction services in European prisons in15 countries during the early phase of the pandemic (March-June 2020). Des[...]Article : Périodique
ENGLISH: Background: People who inject drugs are often imprisoned, which is associated with increased levels of health risks including overdose and infectious diseases transmission, affecting not only people in prison but also the communities t[...]Document texte divers
EMCDDA Conference on 20 years of monitoring and communicating evidence on drugs (21-22 September 2015; Lisbon) ; L. MONTANARI ; B. GUARITA ; A. PIRONA ; I. GIRAUDON ; D. HEDRICH ; R. SIMON ; J. VICENTE | Lisbon : OEDT / EMCDDA | 2015Comparable and reliable information on the numbers and characteristics of those entering specialised drug treatment in EU Member States is essential for understanding the European drug problem. The EMCDDA has been collecting data on drug treatme[...]